Recently, SPD supplementation has also been reported to mitigate intestinal tumorigenesis in APC-mutated mice [13], suggesting its possible use in patients with FAP or in individuals at risk of CRC onset or recurrence. This evidence concerns the gene APC and Familial adenomatous polyposis.